Åse Rosenqvist

Nordic Business Unit Lead Cell Therapy • Janssen

Mrs. Rosenqvist holds a position on the Board of CAMP ATMP Sweden and serves as the Nordic Cell Therapy lead at Janssen, a division of Johnson&Johnson. Her expertise lies in guiding pharmaceutical companies toward innovative approaches in Europe. She excels at fostering collaboration among various stakeholders within the healthcare system, academia, universities, authorities, and the life science sector. Through her inclusive and inspiring leadership style, she empowers individuals and harnesses their potential.

Also speaking

Michal Besser

Chief Technology Officer, Davidoff Cancer Center • Rabin Medical Center

Ingrid Gafanhão

Equity Research Analyst, Healthcare • Bryan, Garnier & Co.

David Del Bourgo

Chief Executive Officer • WhiteLab Genomics

Event Info


Advanced Therapies Investment Summit

Find out more about the Investor Pre-Day taking place 10th September 2024.

2023 Sample Attendee List

Take a look at the sample attendee list for Advanced Therapies Europe 2023 here.